FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Siemens Healthineers AG Stock AnalysisComprehensive stock analysis for Siemens Healthineers AG (SEMHF) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSEMHF
SEMHF
Siemens Healthineers AG
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SEMHF
Home🔹Stocks🔹Siemens Healthineers AG

Siemens Healthineers AG

🇺🇸SEMHF•OTC

Siemens Healthineers AG

🇺🇸SEMHF•OTC
Market cap
$56.29B
Sentiment

Your view on SEMHF

Mkt Cap
$56.29B
Sentiment
Your view
SEMHF
Siemens Healthineers AG
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
SEMHF
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Siemens Healthineers AG

Industry
Medical - Devices
Sector
Healthcare
CEO
Bernhard Montag
Headquarters
Henkestrasse 127, Forchheim, DE
Industry
Medical - Devices
Sector
Healthcare
CEO
Bernhard Montag
Headquarters
Henkestrasse 127, Forchheim, DE
Description

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies.

The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.

The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products.

The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy.

The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions.

It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany.

Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Siemens Healthineers AG, and the rating behind it. SEMHF last traded at $50.40, 19.3× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Siemens Healthineers AG. Starting points for Siemens Healthineers AG: P/E 19.3, EPS $1.98, beta 0.81 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Siemens Healthineers AG. Siemens Healthineers AG does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Siemens Healthineers AG. Trailing twelve-month EPS for Siemens Healthineers AG stands at $1.98. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Siemens Healthineers AG. Siemens Healthineers AG has reported as a listed company since 2023. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Siemens Healthineers AG valued side by side against its closest peers. Siemens Healthineers AG is measured against Medical - Devices peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Siemens Healthineers AG, and how their positions are changing. At a $56.29B market value, institutional positions materially move Siemens Healthineers AG's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Siemens Healthineers AG executives and directors. Shares of Siemens Healthineers AG have traded between $46.01 and $60.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Siemens Healthineers AG. Siemens Healthineers AG is a $56.29B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Siemens Healthineers AG. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Siemens Healthineers AG. Coverage tracks Siemens Healthineers AG within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • ARGNF — argenx SE
  • CHGCF — Chugai Pharmaceutical Co., Ltd.
  • CHGCY — Chugai Pharmaceutical Co., Ltd.
  • CMXHF — CSL Limited
  • HOCPF — HOYA Corporation
  • HOCPY — HOYA Corporation
  • LZAGY — Lonza Group AG
  • MKGAF — Merck KGaA

More Medical - Devices companies

  • BBNX — Beta Bionics, Inc.
  • BCCOY — BICO Group AB (publ)
  • BDMD — Baird Medical Investment Holdings Limited
  • BFLY — Butterfly Network, Inc.
  • BIIO — Bionovate Technologies Corp
  • BIO — Bio-Rad Laboratories, Inc.
  • BIO-B — Bio-Rad Laboratories, Inc.
  • BJDX — Bluejay Diagnostics, Inc.
  • BMRA — Biomerica, Inc.
  • BRKR — Bruker Corporation
  • BRKRP — Bruker Corporation
  • BRNHF — Broncus Holding Corporation

News

Latest Market News